Panthera Biopartners
Heena D. has four years of work experience in the medical field. In 2020, they began working at Panthera Biopartners as a Project Coordinator and Clinical Trial Support Officer. Heena also began working at Synexus Clinical Research Ltd as a Clinical Trials Technician. In 2019, they worked at Positive Solutions as a Business Relationship Manager. In 2017, they began working at Synexus Clinical Research Ltd as a Clinical Trials Technican.
Heena D. obtained a Pharmacy degree from Keele University between 2008 and 2013. In October 2022, they obtained a PRINCE2® Foundation Certification Training from Learning People Global, and in December 2022 they obtained a PRINCE2® 2017 Project Management Certifications from the same institution.
This person is not in any offices
Panthera Biopartners
1 followers
Panthera Biopartners, established in 2019, is a leading UK-based Site Management Organisation (SMO) specialising in patient recruitment and the execution of clinical trials across various therapeutic areas. Founded by Dr Ian Smith, the originator of Synexus, and Professor John Lyon, a former global executive at Covance, Panthera has rapidly expanded its network to include dedicated clinical trial sites in major UK cities such as Glasgow, London, Manchester, Preston, Sheffield and York The organisation's mission is to enhance healthcare accessibility by conducting clinical research that integrates diverse insights and expertise. Panthera is committed to maintaining rigorous ethical standards and contributing to medical advancements that positively impact health and well-being. Panthera's management team comprises experienced professionals with extensive knowledge in conducting clinical trials across multiple therapy areas and countries. Key figures include Dr Ian Smith (Co-Founder, Director, and Chief Medical Officer), Stuart Young (Chief Executive Officer), and Chris Dodd (Chief Commercial Officer). In October 2024, Panthera became the first UK clinical trial site organisation to join Parexel’s Site Alliance Vaccine Network, a global consortium of high-performing clinical trial sites. This collaboration underscores Panthera's exceptional performance in patient recruitment and its strong partnership with Parexel. Panthera's dedication to innovation and excellence was recognised in October 2023 when it was named Pharma Research Centre of the Year at the Pharma Industry Awards UK. The award highlighted Panthera's innovative SMO model, which emphasises rapid start-up times, access to a vast pool of prequalified patients, and the digitisation of patient engagement processes.